United States · Biotechnology startup
United States · Cerulean Pharma
Cerulean Pharma develops nanotechnology-based therapeutics for treating oncology, cardiovascular, autoimmune and inflammatory diseases.
Funding reportedLast round: Post ipo equity
What company datasets say Cerulean Pharma raised
Funding, as reported
Reported in all$153Min dollars
Rounds12
Last roundPost ipo equity
Last round dateApr 2015
Investors listed8
Founders and team
From Cerulean Pharma's own website and the SEC filings it signed: 1 founder, 10 on the team.
Sabrina Martucci JohnsonFounder & Chief Executive Officer of Daré Bioscience
- Elizabeth ProosVice President, Product Development
- Jessica HathewayVice President, Clinical Operations
- Mark WaltersVice President, Operations
- Nicolas PacelliVice President, Alliance Management and Business Development
- MarDee Haring-LaytonChief Accounting Officer
- Christine Mauck M.D.Medical Director
- Adrian D.T. SenderowiczExecutive Officeri
- Alejandra V. CarvajalExecutive Officeri
- Christopher D.T. GuiffreExecutive Officer, Directori
- Gregg D.T. BeloffExecutive Officeri
On the board, as filediAlan L. CraneDavid R. ParkinsonDavid R. WaltPaul A. FriedmanStuart A. ArbuckleSusan L. KelleyWilliam H. RastetterWilliam T. McKee
Biotechnology in United States
Startups like it
- SojournixWaltham · founded 2016Raised
- Receptor Life SciencesSeattle · founded 2017Raised
- Attune PharmaceuticalsNew York · founded 2018Raised
AbbVieNorth Chicago · founded 2012
GrailMenlo Park · founded 2015
EQRxCambridge · founded 2019- Cerevel TherapeuticsBoston · founded 2018
Royalty PharmaNew York · founded 1996
Is this your company?
Add your raise, your deck and your story, and put Cerulean Pharma in front of investors. Or tell us what we have wrong.